A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Descripteurs (mots clés)
Thésaurus Mesh
> G > Glucocorticoïdes > Glucocorticoïdes / usage thérapeutique
Glucocorticoïdes / usage thérapeutique
Ajouter le résultat dans votre panier Affiner la recherche
Etendre la recherche sur niveau(x) vers le bas
Dry Needling Versus Cortisone Injection in the Treatment of Greater Trochanteric Pain Syndrome: A Noninferiority Randomized Clinical Trial / Kindlye Brenamm in Journal of Orthopaedic & Sports Physical Therapy, vol.47, 4 (Avril 2017)
[article]
in Journal of Orthopaedic & Sports Physical Therapy > vol.47, 4 (Avril 2017) . - P.232-239
Titre : Dry Needling Versus Cortisone Injection in the Treatment of Greater Trochanteric Pain Syndrome: A Noninferiority Randomized Clinical Trial Type de document : article de périodique Auteurs : Kindlye Brenamm ; [et al.] Année de publication : 2017 Article en page(s) : P.232-239 Langues : Français (fre) Descripteurs (mots clés) : [Thésaurus Mesh]:B:Bursite:Bursite / rééducation et réadaptation
[Thésaurus Mesh]:B:Bursite:Bursite / thérapie
[Thésaurus Mesh]:G:Glucocorticoïdes:Glucocorticoïdes / usage thérapeutique
[Thésaurus Mesh]GlucocorticoïdesRésumé : Study Design Prospective, randomized, partially blinded.
Background
Greater trochanteric pain syndrome (GTPS) is the current terminology for what was once called greater trochanteric or subgluteal bursitis. Cortisone (corticosteroid) injection into the lateral hip has traditionally been the accepted treatment for this condition; however, the effectiveness of injecting the bursa with steroids is increasingly being questioned. An equally effective treatment with fewer adverse side effects would be beneficial.
Objective
To investigate whether administration of dry needling (DN) is noninferior to cortisone injection in reducing lateral hip pain and improving function in patients with GTPS.
Methods
Forty-three participants (50 hips observed), all with GTPS, were randomly assigned to a group receiving cortisone injection or DN. Treatments were administered over 6 weeks, and clinical outcomes were collected at baseline and at 1, 3, and 6 weeks. The primary outcome measure was the numeric pain-rating scale (0–10). The secondary outcome measure was the Patient-Specific Functional Scale (0–10). Medication intake for pain was collected as a tertiary outcome.
Results
Baseline characteristics were similar between groups. A noninferiority test for a repeated-measures design for pain and averaged function scores at 6 weeks (with a noninferiority margin of 1.5 for both outcomes) indicated noninferiority of DN versus cortisone injection (both, P<.01). Medication usage (P = .74) was not different between groups at the same time point. No adverse side effects were reported.
Conclusion
Cortisone injections for GTPS did not provide greater pain relief or reduction in functional limitations than DN. Our data suggest that DN is a noninferior treatment alternative to cortisone injections in this patient population.
Level of Evidence
Therapy, level 1b.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité J Périodique Erasme - périodiques Périodiques Disponible J Périodique Erasme - périodiques Périodiques Disponible